14th Mar 2023 7:00 am |
RNS |
Appointment of Joint Broker |
13th Mar 2023 7:00 am |
RNS |
Statement re. Silicon Valley Bank |
7th Mar 2023 7:00 am |
RNS |
Health economics publication |
27th Feb 2023 7:00 am |
RNS |
Data on cost-effectiveness of LungLB® |
20th Feb 2023 7:00 am |
RNS |
Preliminary results for year ended 31 Dec 2022 |
8th Feb 2023 7:00 am |
RNS |
Notice of Results |
7th Dec 2022 2:37 pm |
RNS |
Holding(s) in Company |
30th Nov 2022 7:00 am |
RNS |
Final Pricing Determination |
30th Nov 2022 7:00 am |
RNS |
Total Voting Rights |
15th Nov 2022 7:00 am |
RNS |
Block Listing Six Monthly Return |
3rd Nov 2022 7:00 am |
RNS |
Director share purchases |
17th Oct 2022 7:00 am |
RNS |
Participation in National Cancer Institute’s EDRN |
26th Sep 2022 7:00 am |
RNS |
Half-year Report |
9th Sep 2022 7:00 am |
RNS |
Notice of Results |
2nd Sep 2022 7:00 am |
RNS |
New York State approval for commercial testing |
16th May 2022 7:00 am |
RNS |
Block Listing Six Monthly Return |
11th May 2022 3:17 pm |
RNS |
Result of AGM |
8th Apr 2022 7:00 am |
RNS |
Publication of AR and Accounts & Notice of AGM |
28th Mar 2022 7:00 am |
RNS |
Preliminary Results |
17th Mar 2022 7:00 am |
RNS |
VA sites in validation study; SAB appointment |
2nd Feb 2022 7:00 am |
RNS |
First patient enrolment for LungLB® study |
4th Jan 2022 7:00 am |
RNS |
CPT® Code granted by American Medical Association |
19th Nov 2021 7:00 am |
RNS |
LungLife AI Laboratory achieves CAP accreditation |
10th Nov 2021 7:00 am |
RNS |
Block Listing Application |
12th Oct 2021 7:00 am |
RNS |
PLA Code application submitted |
9th Sep 2021 7:00 am |
RNS |
Half-year Report |
3rd Sep 2021 7:00 am |
RNS |
Notice of Results |
28th Jul 2021 3:08 pm |
RNS |
Holding(s) in Company |
12th Jul 2021 9:15 am |
RNS |
Holding(s) in Company |
9th Jul 2021 3:35 pm |
RNS |
Holding(s) in Company |
8th Jul 2021 3:45 pm |
RNS |
Holding(s) in Company |
8th Jul 2021 8:00 am |
RNS |
Director/PDMR Shareholding |
8th Jul 2021 7:00 am |
RNS |
Admission to AIM & First Day of Dealings |